Key result
Myosin light chain 3 (MmMYL3) acts as a novel receptor for red-spotted grouper nervous necrosis virus, facilitating its entry into host cells via the macropinocytosis pathway.
Why the study?
Nervous necrosis virus causes severe mortality in fish populations, but the host factors involved in its entry remain poorly understood.
Myosin light chain 3 (MYL3) acts as a novel receptor for nervous necrosis virus entry, presenting a potential antiviral target for fish populations.
Suggests MmMYL3 blockade to limit RGNNV entry in fish; leaves open in vivo efficacy and aquaculture applications.
Nodaviridae infections cause severe mortality in insects and fish, with nervous necrosis virus (NNV) posing significant threats to global fish populations. However, the host factors involved in NNV entry remain poorly understood. We identify myosin light chain 3 from marine medaka ( Oryzias melastigma ) (MmMYL3) as a novel receptor for red-spotted grouper NNV (RGNNV), facilitating internalization via macropinocytosis. MmMYL3 directly binds the RGNNV capsid protein (CP), which depends on the arm and S domains of CP and the EF-hand2 domain of MmMYL3. In vitro experiments showed that MmMYL3 siRNA, protein, anti-MYL3 antibodies, or the arm domain synthetic peptides blocked RGNNV entry. Moreover, in vivo administration of MmMYL3 protein also inhibited RGNNV infection. Ectopic MmMYL3 expression enabled RGNNV internalization into resistant cells. Notably, MmMYL3 facilitated RGNNV internalization through the macropinocytosis pathway via the IGF1R-Rac1/Cdc42 axis. Collectively, our findings underscore MYL3’s crucial role in NNV entry and its potential as an antiviral target.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) studied Nervous necrosis virus (NNV) infection. MmMYL3 siRNA, protein, anti-MYL3 antibodies, or arm domain synthetic peptides was evaluated on RGNNV entry and infection. Myosin light chain 3 (MmMYL3) acts as a novel receptor for red-spotted grouper nervous necrosis virus, facilitating its entry into host cells via the macropinocytosis pathway.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: